Skip to main content
SpringerLink
Log in

Evaluation of Premature Ejaculation

  • Chapter
  • First Online:
The Textbook of Clinical Sexual Medicine

  • 2931 Accesses

Abstract

Premature ejaculation (PE) has given rise to various and sometimes highly contrasting theories, approaches, and treatments. PE was believed to be mainly a psychological disorder for the first half of the twentieth century and regarded as a symptom of a neurosis that had to be treated by psychoanalysis in order to solve the unconscious conflicts that were assumed to have caused the neurosis. Years ahead of his time, Bernard Schapiro advocated oral and local anesthetic drug treatment to delay ejaculation. In 1994, Waldinger introduced the intravaginal ejaculation latency time (IELT) as a scientific measure of the ejaculation time, using a stopwatch. In addition to Schapiro’s two PE subtypes (Lifelong and Acquired), Waldinger and Schweitzer postulated the existence of two additional PE subtypes: Subjective PE and Variable PE. The classification of PE into four PE subtypes is relevant for pharmacotherapy and counseling of men with complaints of PE. The pathophysiology of lifelong PE is mediated by a very complex interplay of central and peripheral serotonergic, dopaminergic, oxytocinergic, endocrinological, genetic, and probably also epigenetic factors. This chapter discusses the progress in PE research including evidence based evaluation methods.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
eBook
USD 139.00
Price excludes VAT (USA)
Softcover Book
USD 179.99
Price excludes VAT (USA)
Hardcover Book
USD 249.99
Price excludes VAT (USA)

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gross S. Practical treatise on impotence and sterility. Edinburgh: YJ Pentland; 1887.

    Google Scholar 

  2. Waldinger MD. The neurobiological approach to premature ejaculation. J Urol. 2002;168:2359–67.

    Article  PubMed  Google Scholar 

  3. Waldinger MD. Lifelong premature ejaculation: from authority-based to evidence-based medicine. BJU Int. 2004;93:201–7.

    Article  CAS  PubMed  Google Scholar 

  4. Schapiro B. Premature ejaculation, a review of 1130 cases. J Urol. 1943;50:374–9.

    Google Scholar 

  5. Schapiro B. Präjaculin. Kombiniertes Epiphysen-Präparat gegen Reizzustände am Genitale und Hypererotismus. Hamburg: Chemische Farbrik Promonta G.m.b.H; 1932.

    Google Scholar 

  6. Waldinger MD. Recent advances in the classification, neurobiology and treatment of premature ejaculation. In: Balon R, editor. Sexual dysfunction. The brain-body connection. Advances in psychosomatic medicine, vol. 29. Basel: Karger; 2008. p. 50–69.

    Google Scholar 

  7. Godpodinoff ML. Premature ejaculation: clinical subgroups and etiology. J Sex Marital Ther. 1989;15:130–4.

    Article  CAS  PubMed  Google Scholar 

  8. Waldinger MD. Ejaculatio praecox, erectio praecox, and detumescentia praecox as symptoms of a hypertonic state in lifelong premature ejaculation: a new hypothesis. Pharmacol Biochem Behav. 2014;121:189–94.

    Article  CAS  PubMed  Google Scholar 

  9. Masters WH, Johnson VE. Premature ejaculation. In: Masters WH, Johnson VE, editors. Human sexual inadequacy. Boston: Little, Brown; 1970. p. 92–115.

    Google Scholar 

  10. Semans JH. Premature ejaculation: a new approach. South Med J. 1956;49:353.

    Article  CAS  PubMed  Google Scholar 

  11. Waldinger MD, Hengeveld MW, Zwinderman AH. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry. 1994;151:1377–9.

    Article  CAS  PubMed  Google Scholar 

  12. Waldinger MD. Towards evidence-based drug treatment research on premature ejaculation: a critical evaluation of methodology. Int J Impot Res. 2003;15:309–13.

    Article  CAS  PubMed  Google Scholar 

  13. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation. Int J Psychiatry Clin Pract. 1998;2:287–93.

    Article  CAS  PubMed  Google Scholar 

  14. Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, Becher EF, Dean J, Giuliano F, Hellstrom WJ, Giraldi A, Glina S, Incrocci L, Jannini E, McCabe M, Parish S, Rowland D, Segraves RT, Sharlip I, Torres LO. An evidence- based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. J Sex Med. 2014;11:1423–41.

    Article  PubMed  Google Scholar 

  15. Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multi-national population survey of intravaginal ejaculation latency time. J Sex Med. 2005;2:492–7.

    Article  PubMed  Google Scholar 

  16. Waldinger MD, McIntosh J, Schweitzer DH. A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. J Sex Med. 2009;6:2888–95.

    Article  PubMed  Google Scholar 

  17. Waldinger MD, Schweitzer DH. Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part I: validity of DSM-IV-TR. J Sex Med. 2006;3:682–92.

    Article  PubMed  Google Scholar 

  18. Waldinger MD, Schweitzer DH. Changing paradigms from an historical DSM-III and DSM-IV view towards an evidence based definition of premature ejaculation. Part II: proposals for DSM-V and ICD-11. J Sex Med. 2006;3:693–705.

    Article  PubMed  Google Scholar 

  19. Waldinger MD, Schweitzer DH. The use of old and recent DSM definitions of premature ejaculation in observational studies: a contribution to the present debate for a new classification of PE in the DSM-V. J Sex Med. 2008;5:1079–87.

    Article  PubMed  Google Scholar 

  20. Waldinger MD. Premature ejaculation: different pathophysiologies and etiologies determine its treatment. J Sex Marital Ther. 2008;34:1–13.

    Article  PubMed  Google Scholar 

  21. Waldinger MD. History of premature ejaculation. In: Jannini EA, McMahon CG, Waldinger MD, editors. Premature ejaculation. From etiology to diagnosis and treatment. Italia: Springer-Verlag; 2013. p. 5–24.

    Google Scholar 

  22. Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl. 2005;28(Suppl 2):40–5.

    Article  PubMed  Google Scholar 

  23. Carani C, Isidori AM, Granata A, Carosa E, Maggi M, Lenzi A, Jannini EA. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab. 2005;90:6472–9.

    Article  CAS  PubMed  Google Scholar 

  24. Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology. 2001;58:198–202.

    Article  CAS  PubMed  Google Scholar 

  25. Corona G, Jannini EA, Vignozzi L, Rastrelli G, Maggi M. The hormonal control of ejaculation. Nat Rev Urol. 2012;9:508–19.

    Article  CAS  PubMed  Google Scholar 

  26. Waldinger MD, Berendsen HHG, Blok BFM, Olivier B, Holstege G. Premature ejaculation and serotonergic antidepressants-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res. 1998b;92:111–8.

    Article  CAS  PubMed  Google Scholar 

  27. Olivier B, van Oorschot R, Waldinger MD. Serotonin, serotonergic receptors, selective serotonin reuptake inhibitors and sexual behaviour. Int Clin Psychopharmacol. 1998;13(Suppl 6):S9–S14.

    Article  PubMed  Google Scholar 

  28. Waldinger MD. The pathophysiology of lifelong premature ejaculation. Transl Androl Urol. 2016;5:424–33.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Waldinger MD. Premature ejaculation: state of the art. Urol Clin North Am. 2007;34:591–9.

    Article  PubMed  Google Scholar 

  30. Saitz TR, Serefoglu EC. The epidemiology of premature ejaculation. Transl Androl Urol. 2016;5:409–15.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Serefoglu EC, Cimen HI, Atmaca AF, Balbay MD. The distribution of patients who seek treatment for the complaint of ejaculating prematurely according to the four premature ejaculation syndromes. J Sex Med. 2010;7:810–5.

    Article  PubMed  Google Scholar 

  32. Serefoglu EC, Yaman O, Cayan S, Asci R, Orhan I, Usta MF, Ekmekcioglu O, Kendirci M, Semerci B, Kadioglu A. The comparison of premature ejaculation assessment questionnaires and their sensitivity for the four premature ejaculation syndromes: results from the Turkish society of andrology sexual health survey. J Sex Med. 2011;8:1177–85.

    Article  PubMed  Google Scholar 

  33. Zhang X, Gao J, Liu J, Xia L, Yang J, Hao Z, Zhou J, Liang C. Distribution and factors associated with four premature ejaculation syndromes in outpatients complaining of ejaculating prematurely. J Sex Med. 2013;10:1603–11.

    Article  PubMed  Google Scholar 

  34. Gao J, Zhang X, Su P, Liu J, Xia L, Yang J, Shi K, Tang D, Hao Z, Zhou J, Liang C. Prevalence and factors associated with the complaint of premature ejaculation and the four premature ejaculation syndromes: a large observational study in china. J Sex Med. 2013;10:1874–81.

    Article  PubMed  Google Scholar 

  35. Janssen PKC, Waldinger MD. The mathematical formula of the intravaginal ejaculation latency time (IELT) distribution of lifelong premature ejaculation differs from the IELT distribution formula of men in the general male population. Investig Clin Urol. 2016;57:119–28.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Ahlenius S, Larsson K, Svensson L, Hjorth S, Carlsson A, Lindberg P, Wilkstrom H, Sanchez D, Arvidsson LE, Hacksell U, Nilsson JL. Effects of a new type of 5-HT receptor agonist on male rat sexual behavior. Pharmacol Biochem Behav. 1981;15:785–92.

    Article  CAS  PubMed  Google Scholar 

  37. Berendsen HH, Broekkamp CL. Drug-induced penile erections in rats: indications of serotonin1B receptor mediation. Eur J Pharmacol. 1987;135:279–87.

    Article  CAS  PubMed  Google Scholar 

  38. Foreman MM, Love RL, Hall JL. Effects of LY237733, a selective 5-HT2 receptor antagonist, on copulatory behavior of male rats. Soc Neurosci Abstr. 1988;14:374.

    Google Scholar 

  39. Waldinger MD. Risk factors in premature ejaculation: the genetic risk factor. In: Jannini EA, McMahon CG, Waldinger MD, editors. Premature ejaculation. From etiology to diagnosis and treatment. Italia: Springer-Verlag; 2013. p. 111–23.

    Google Scholar 

  40. Waldinger MD, Rietschel M, Nothen MM, Hengeveld MW, Olivier B. Familial occurrence of primary premature ejaculation. Psychiatr Genet. 1998c;8:37–40.

    Article  CAS  PubMed  Google Scholar 

  41. Janssen PK, Bakker SC, Réthelyi J, Zwinderman AH, Touw DJ, Olivier B, Waldinger MD. Serotonin transporter promoter region (5-HTTLPR) polymorphism is associated with the intravaginal ejaculation latency time in Dutch men with lifelong premature ejaculation. J Sex Med. 2009;6:276–84.

    Article  CAS  PubMed  Google Scholar 

  42. Janssen PKC, van Schaik R, Zwinderman AH, Olivier B, Waldinger MD. The 5-HT1A receptor C(1019)G polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation. Pharmacol Biochem Behav. 2014; 121:184–8.

    Google Scholar 

  43. Janssen PKC, van Schaik R, Olivier B, Waldinger MD. The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation Asian J Androl 2014;16:607–10.

    Google Scholar 

  44. Jern P, Eriksson E, Westberg L. A reassessment of the possible effects of the serotonin transporter gene linked polymorphism 5-HTTLPR on premature ejaculation. Arch Sex Behav. 2013;42:45–9.

    Article  PubMed  Google Scholar 

  45. Zuccarello D, Ghezzi M, Pengo M, Forzan M, Frigo AC, Ferlin A, Foresta C. No difference in 5-HTTLPR and Stin2 Polymorphisms frequency between premature ejaculation patients and controls. J Sex Med. 2012;9:1659–68.

    Article  CAS  PubMed  Google Scholar 

  46. Safarinejad MR. Polymorphisms of the serotonin transporter gene and their relation to premature ejaculation in individuals from Iran. J Urol. 2009;181:2656–61.

    Article  CAS  PubMed  Google Scholar 

  47. Ozbek E, Tasci AI, Tugcu V, Ilbey YO, Simsek A, Ozcan L, Polat EC, Koksal V. Possible association of the 5-HTTLPR serotonin transporter promoter gene polymorphism with premature ejaculation in a Turkish population. Asian J Androl. 2009;11:351–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Luo SW, Wang F, Xie ZY, Huang XK, Lu YP. Study on the correlation of the 5-HTTLPR polymorphism with premature ejaculation in Han Chinese population. Beijing Da Xue Xue Bao. 2011;43:514–8.

    CAS  PubMed  Google Scholar 

  49. Janssen PKC, Olivier B, Zwinderman AH, Waldinger MD. Measurement errors in polymerase chain reaction are a confounding factor for a correct interpretation of 5-HTTLPR polymorphism effects on lifelong premature ejaculation: a critical analysis of a previously published meta-analysis of six studies. PLoS One. 2014 Mar 3;9(3):e88031.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Jern P, Westberg L, Johansson A, Gunst A, Eriksson E, Sandnabba K, Santtila P. A study of possible associations between single nucleotide polymorphisms in the serotonin receptor 1A, 1B, and 2C genes and self-reported ejaculation latency time. J Sex Med. 2012;9:866–72.

    Article  CAS  PubMed  Google Scholar 

  51. McMahon CG, Althof S, Waldinger MD, Porst H, Dean J, Sharlip I, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJ, Incrocci L, Laan E, Meuleman E, Perelman MA, Rosen R, Rowland D, Segraves R. An evidence-based definition of lifelong premature ejaculation: report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med. 2008;5:1590–606.

    Article  PubMed  Google Scholar 

  52. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th edition) (DSM-5). Washington, DC: American Psychiatric Association; 2013.

    Book  Google Scholar 

  53. Waldinger MD. Pharmacotherapy for premature ejaculation. Expert Opin Pharmacother. 2015;16:2615–24.

    Article  CAS  PubMed  Google Scholar 

  54. de Jong TR, Veening JG, Olivier B, Waldinger MD. Oxytocin involvement in SSRI-induced delayed ejaculation: a review of animal studies. J Sex Med. 2007;4:14–28.

    Article  PubMed  Google Scholar 

  55. Melis MR, Argiolas A, Gessa GL. Oxytocin-induced penile erection and yawning: site of action in the brain. Brain Res. 1986;398:259–65.

    Article  CAS  PubMed  Google Scholar 

  56. Peeters M, Giuliano F. Central neurophysiology and dopaminergic control of ejaculation. Neurosci Biobehav Rev. 2008;32:438–53.

    Article  CAS  PubMed  Google Scholar 

  57. Chen K, Chang LS. Oxytocinergic neurotransmission at the hippocampus in the central neural regulation of penile erection in the rat. Urology. 2001;58:107–12.

    Article  CAS  PubMed  Google Scholar 

  58. Zhang XH, Filippi S, Vignozzi L, Morelli A, Mancina R, Luconi M, Donati S, Marini M, Vannelli GB, Forti G, Maggi M. Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. J Endocrinol. 2005;184:567–76.

    Article  CAS  PubMed  Google Scholar 

  59. Stoneham MD, Everitt BJ, Hansen S, Lightman SL, Todd K. Oxytocin and sexual behaviour in the male rat and rabbit. J Endocrinol. 1985;107:97–106.

    Article  CAS  PubMed  Google Scholar 

  60. Hughes AM, Everitt BJ, Lightman SL, Todd K. Oxytocin in the central nervous system and sexual behaviour in male rats. Brain Res. 1987;414:133–7.

    Article  CAS  PubMed  Google Scholar 

  61. Uckert S, Becker AJ, Ness BO, Stief CG, Scheller F, Knapp WH, Jonas U. Oxytocin plasma levels in the systemic and cavernous blood of healthy males during different penile conditions. World J Urol. 2003;20:323–6.

    PubMed  Google Scholar 

  62. Kruger TH, Haake P, Chereath D, Knapp W, Janssen OE, Exton MS, Schedlowski M, Hartmann U. Specificity of the neuroendocrine response to orgasm during sexual arousal in men. J Endocrinol. 2003;177:57–64.

    Article  CAS  PubMed  Google Scholar 

  63. Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM. Plasma oxytocin increases in the human sexual response. J Clin Endocrinol Metab. 1987;64:27–31.

    Article  CAS  PubMed  Google Scholar 

  64. Murphy MR, Seckl JR, Burton S, Checkley SA, Lightman SL. Changes in oxytocin and vasopressin secretion during sexual activity in men. J Clin Endocrinol Metab. 1987;65:738–41.

    Article  CAS  PubMed  Google Scholar 

  65. Waldinger MD. Premature ejaculation: definition and drug treatment. Drugs. 2007;67:547–68.

    Article  CAS  PubMed  Google Scholar 

  66. Althof SE. Patient reported outcomes in the assessment of premature ejaculation. Transl Androl Urol. 2016;5:470–4.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Patrick DL, Giuliano F, Ho KF, et al. The premature ejaculation profile: validation of self-reported outcome measures for research and practice. BJU Int. 2009;103:358–64.

    Article  PubMed  Google Scholar 

  68. Althof S, Rosen R, Symonds T, et al. Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation. J Sex Med. 2006;3:465–75.

    Article  PubMed  Google Scholar 

  69. Symonds T, Perelman MA, Althof S, et al. Development and validation of a premature ejaculation diagnostic tool. Eur Urol. 2007;52:565–73.

    Article  PubMed  Google Scholar 

  70. Symonds T, Perelman M, Althof S, et al. Further evidence of the reliability and validity of the premature ejaculation diagnostic tool. Int J Impot Res. 2007;19:521–5.

    Article  CAS  PubMed  Google Scholar 

  71. Arafa M, Shamloul R. Development and evaluation of the Arabic Index of Premature Ejaculation (AIPE). J Sex Med. 2007;4:1750–6.

    Article  PubMed  Google Scholar 

  72. Yuan YM, Xin ZC, Jiang H, et al. Sexual function of premature ejaculation patients assayed with Chinese Index of Premature Ejaculation. Asian J Androl. 2004;6:121–6.

    PubMed  Google Scholar 

  73. Ventus D, Ristila M, Gunst A, Karna A, Arver S, Piha J, Jern P. A longitudinal analysis of premature ejaculation symptoms raises concern regarding the appropriateness of a “lifelong” subtype. Eur Urol Focus. 2017 (in press).

    Google Scholar 

  74. Waldinger MD. Editorial. The danger that threatens current research of premature ejaculation: use of validated questionnaires, performing cnjuring tricks with statistics, and refusing to use realtime stopwatch measurements of the IELT. 2017 (in press).

    Google Scholar 

  75. Zhu L, Mi Y, You X, Wu S, Shao H, et al. A meta-analysis of the effects of the 5-hydroxytryptamine transporter gene-linked promoter region polymorphism on susceptibility to lifelong premature ejaculation. PLoS One. 2013;8(1):e54994.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, USA

    Marcel D. Waldinger

  2. Private Practice in Psychiatry and Neurosexology, Amstelveen, The Netherlands

    Marcel D. Waldinger

Authors
  1. Marcel D. Waldinger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marcel D. Waldinger .

Editor information

Editors and Affiliations

  1. Cedars-Sinai Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, USA

    Waguih William IsHak

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Waldinger, M.D. (2017). Evaluation of Premature Ejaculation. In: IsHak, W. (eds) The Textbook of Clinical Sexual Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-52539-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-52539-6_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-52538-9

  • Online ISBN: 978-3-319-52539-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation